Publication details

 

Clinical impact of CYP2D6 activity in long-term paroxetine treatment

Basic information
Original title:Clinical impact of CYP2D6 activity in long-term paroxetine treatment
Authors:Alexandra Žourková, Eva Hadašová, Lucie Pulkrábková, Barbora Ravčuková, Tomáš Kašpárek
Further information
Citation:ŽOURKOVÁ, Alexandra, Eva HADAŠOVÁ, Lucie PULKRÁBKOVÁ, Barbora RAVČUKOVÁ a Tomáš KAŠPÁREK. Clinical impact of CYP2D6 activity in long-term paroxetine treatment. In New developments in anxiety disorder research. New York: Nova Science Publishers, 2006. s. 177-198, 21 s. 1 edition (2006/6/14). ISBN 1-59454-778-5.Export BibTeX
@inbook{702291,
author = {Žourková, Alexandra and Hadašová, Eva and Pulkrábková, Lucie and Ravčuková, Barbora and Kašpárek, Tomáš},
address = {New York},
booktitle = {New developments in anxiety disorder research},
keywords = {anxiety disorder - paroxetine - side effects - CYP2D6 - phenotype - genotype},
language = {eng},
location = {New York},
isbn = {1-59454-778-5},
pages = {177-198},
publisher = {Nova Science Publishers},
title = {Clinical impact of CYP2D6 activity in long-term paroxetine treatment},
year = {2006}
}
Original language:English
Field:Psychiatry, sexuology
Type:Chapter of a book
Keywords:anxiety disorder - paroxetine - side effects - CYP2D6 - phenotype - genotype

The aim of study was comparison of distribution of therapeutic efficaccy and side effects of long-term paroxetine treatment according to metabolic status. Statistically significant difference was only in poor metabolisers CYP2D6 in severity of sexual dysfunction.

Related projects: